A citation-based method for searching scientific literature

S Depil, P Duchateau, S A Grupp, G Mufti, L Poirot. Nat Rev Drug Discov 2020
Times Cited: 321



C Imai, K Mihara, M Andreansky, I C Nicholson, C-H Pui, T L Geiger, D Campana. Leukemia 2004
Times Cited: 512




List of shared articles



Times cited

Cancer immunotherapy: Challenges and limitations.
Sina Taefehshokr, Aram Parhizkar, Shima Hayati, Morteza Mousapour, Amin Mahmoudpour, Liliane Eleid, Dara Rahmanpour, Sahand Fattahi, Hadi Shabani, Nima Taefehshokr. Pathol Res Pract 2022
15

Development of a cGMP-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cells.
Young-In Kim-Hoehamer, Janice M Riberdy, Fei Zheng, Jeoungeun J Park, Na Shang, Jean-Yves Métais, Timothy Lockey, Catherine Willis, Salem Akel, Jennifer Moore,[...]. Gene Ther 2022
0

Prospects for CAR T cell immunotherapy in autoimmune diseases: clues from Lupus.
Marko Radic, Indira Neeli, Tony Marion. Expert Opin Biol Ther 2022
1


iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting.
Benjamin H Goldenson, Pooja Hor, Dan S Kaufman. Front Immunol 2022
7

The Past, Present, and Future of Clinically Applied Chimeric Antigen Receptor-T-Cell Therapy.
Yuki Fujiwara, Toshiki Kato, Futoshi Hasegawa, Muha Sunahara, Yoshie Tsurumaki. Pharmaceuticals (Basel) 2022
1

CAR T Cell Immunotherapy Beyond Haematological Malignancy.
Cedric Hupperetz, Sangjoon Lah, Hyojin Kim, Chan Hyuk Kim. Immune Netw 2022
1


CAR-T Therapy in Clinical Practice: Technical Advances and Current Challenges.
Ping Ren, Chuyue Zhang, Wenping Li, Xian Wang, Aibing Liang, Guang Yang, Hongtao Xu, Peixiang Ma. Adv Biol (Weinh) 2022
0